"Greenwich LifeSciences Announces Poster Presentation of Five Year Data for GP2 Phase IIb Clinical Trial, Showing 0% Recurrence of Breast Cancer."
More from Stocks
These recently downgraded names are displaying both quantitative and technical deterioration.
Luck impacts our trading much more than we realize. Acknowledging that fact can help improve results.
Risk-averse investors can reduce portfolio volatility by buying quality dividend growth stocks.
While indices are hitting all-time highs, 60% of stocks are struggling or in outright bear markets.